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Diagnostic Evaluation of Anaemia  
Vikrant Kale and Abdur Rahmaan Aftab 
Gastroenterology Department, 
St.Luke’s Hospital, Kilkenny 
Ireland 
1. Introduction 
Anaemia is one of the major signs of disease. It is never normal and its cause(s) should 
always be sought.  
The history, physical examination, and simple laboratory testing are all useful in evaluating 
the anaemic patient.  
The workup should be directed towards answering the following questions concerning 
whether one or more of the major processes leading to anaemia may be operative: 
 Is the patient bleeding (now or in the past)? 
 Is there evidence for increased RBC destruction (haemolysis)? 
 Is the bone marrow suppressed? 
 Is the patient iron deficient? If so, why? 
 Is the patient deficient in folic acid or vitamin B12? If so, why? 
Depending on the provisional diagnosis, you may need special investigations like radiologic 
tests, bone marrow aspiration, gastrointestinal endoscopies, molecular studies etc. to arrive at a 
definite diagnosis. 
2. History taking  
2.1 Onset, duration and progress 
Insidious onset, long duration and gradual progress of symptoms in a patient with anaemia 
suggests nutritional anaemia, chronic haemolytic anaemia (congenital or acquired), anaemia 
of chronic disease and anaemia due to chronic blood loss. Rapid onset, short duration and 
rapid progress of symptoms indicate acute leukaemia, acute haemolytic anaemia, 
hemolytic/aplastic crisis in chronic haemolytic anaemia, anaemia secondary to acute blood 
loss and infiltrative disorders of the bone marrow. 
Presence of symptoms other than those due to anaemia is a pointer to underlying disease 
causing anaemia and provides clues for further work up of the patient. Inquiry should be 
made to uncover conditions that may cause gastro-intestinal, genito-urinary or any other 
blood loss.  
An anaemic patient who complains of angina or symptoms of cerebral hypoxia  urgently  
needs the oxygen carrying capacity raised by red cell transfusions and inspired oxygen, 
whatever may be the cause of anaemia.Passage of dark red or brown urine indicates 
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haemoglobinuria and suggests haemolysis. History of episodes of bone pain, backache, 
abdominal pain in past suggests the diagnosis of Sickle Cell Disease. 
2.2 Age & sex 
Anaemia is more common in pregnant women, females in reproductive age and children 
during the phase of rapid growth. A predominantly cereal based diet which is poor in green 
leafy vegetables and vitamin C containing foods is a common cause of iron deficiency. 
In a female patient, a detailed menstrual history and history of reproductive performance 
(number of deliveries and interval between deliveries), provide information about stress on 
iron balance and raises the possibility of iron deficiency anaemia. 
Self imposed or improperly advised dietary restrictions can contribute to nutritional 
anaemia. 
2.3 Drug ingestion  
Drug ingestion can cause anaemia in several ways. Long term ingestion of aspirin (in 
patients of coronary artery disease) can lead to chronic blood loss and iron deficiency 
anaemia. Certain drugs can cause haemolysis in individuals with G-6-PD deficiency. 
Rifampicin and alpha methyl dopa can cause autoimmune haemolytic anaemia. 
Chemotherapeutic drugs can cause marrow depression and pancytopenia.  
A past history of cardiac valve surgery can indicate the possibility of haemolysis. 
3. Physical examination 
Clinical examination can provide a wealth of diagnostic information. Although signs are not 
always present, they can be helpful in making a clinical diagnosis.   
A smooth(bald) tongue and nail changes of koilonychia (brittle, flat or concave nails, more 
common in toe nails than in finger nails), and bilateral, painless parotid enlargement in a 
patient with anaemia suggests the diagnosis of iron deficiency anaemia. Skin pigmentation in 
the peri-oral region and over the knuckles is suggestive of megaloblastic anaemia. The 
presence of mild jaundice would suggest possibility of haemolytic anaemia. A generalized 
greyish discoloration of skin indicates iron overload in anaemic patients who have been given 
blood transfusions over several years. Skin pigmentation and various skeletal abnormalities 
may be present in some cases of constitutional hypoplastic anaemia. The presence of petechial 
haemorrhages would indicate a marrow infiltrative disease (leukaemia, lymphoma, 
myeloma, metastases, etc.), they may also be seen in megaloblastic anaemia.  
Fronto-temporal bossing, malar prominence, upper jaw and teeth projecting beyond the 
lower jaw, flat bridge of the nose - all giving rise to typical facial appearance are 
characteristic of Thalassemia syndromes. Puffiness of lower eye lids, loss of eye brow hair and 
thick voice would suggest myxedema as the cause of anaemia; this can be confirmed by 
delayed relaxation of muscle after eliciting deep reflexes. 
The presence of hypertension should alert the clinician to the possibility of anaemia secondary 
to chronic renal failure. 
Tenderness of calf muscles suggests megaloblastic anaemia but could be present even in 
iron deficiency anaemia. Signs of sub-acute combined degeneration indicate pernicious 
anaemia. Lymphadenopathy suggests the possibility of leukaemia or lymphoma.  
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4. Laboratory evaluation  
Lab tests in the diagnosis of Anaemia: 
 
1.Complete Blood Count(CBC) 
 
    A. Red blood cell count 
         - Haemoglobin 
         - Hematocrit(HCT) 
         - Reticulocyte count 
 
    B. Red blood cell indices 
         - Mean cell volume(MCV) 
         - Mean cell haemoglobin(MCH) 
         - Mean cell haemoglobin  
            Concentration(MCHC) 
         - Red cell distribution width 
           (RDW) 
 
    C. White blood cell count 
         - Cell differential 
         - Nuclear segmentation of  
           Neutrophils 
 
    D. Platelet count 
 
    E. Cell morphology 
         - Cell size 
         - Haemoglobin content 
         - Anisocytosis 
         - Poikilocytosis 
         - Polychromasia 
2. Iron supply studies 
 
    A. Serum Iron 
 
    B. Total iron binding capacity 
 
    C. Serum ferritin 
 
    D. Marrow iron stain  
 
3. Marrow examination 
 
    A. Aspirate 
         - M/E ratio* 
         - Cell morphology 
         - Iron stain 
 
    B. Biopsy 
         - Cellularity 
         - Morphology 
M/E ratio – ratio of myeloid to erythroid precursors. 
Source – Harrison’s Principles of Internal Medicine, 16th edition. 
4.1 Mean corpuscular volume 
The normal range for MCV is from 80 to 100 femtoliters (fL). Values in excess of 115 fL are 
almost exclusively seen in vitamin B12 or folic acid deficiency. Even higher values can 
occur as an artefact when cold agglutinins are present, which causes RBCs to go through 
the counting aperture in doublets or triplets. Low values usually indicate a microcytic 
anaemia. 
4.2 Mean corpuscular haemoglobin 
The normal MCH ranges from 27.5 to 33.2 picograms of haemoglobin per RBC. Low values 
are seen in iron deficiency and thalassemia, while increased values occur in macrocytosis of 
any cause. 
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4.3 Mean corpuscular haemoglobin concentration 
The mean normal value for the MCHC is 34 grams of haemoglobin per dL of RBCs. Low 
values occur in the same conditions that generate low values for MCV and MCH, while 
increased values occur almost exclusively in the presence of congenital or acquired 
spherocytosis or in other congenital haemolytic anaemia in which red cells are abnormally 
desiccated (eg, sickle cell anaemia, haemoglobin C disease, xerocytosis).  
4.4 Reticulocyte count 
The reticulocyte count, either as a percentage of all RBCs, the absolute reticulocyte count, 
the corrected absolute reticulocyte count, or as the reticulocyte production index, helps to 
distinguish among the different types of anaemia: 
- Anaemia with a high reticulocyte count reflects an increased erythropoietic response to 
continued haemolysis or blood loss. 
- A stable anaemia with a low reticulocyte count is strong evidence for deficient 
production of RBCs (ie, a reduced marrow response to the anaemia).  
- Haemolysis or blood loss can be associated with a low reticulocyte count if there is a 
concurrent disorder that impairs RBC production (eg, infection, prior chemotherapy). 
- A low reticulocyte percentage accompanied by pancytopenia is suggestive of aplastic 
anaemia, while a reticulocyte percentage of zero with normal white blood cell and 
platelet counts suggests a diagnosis of pure red cell aplasia.  
4.5 White blood cell count and differential 
A low total white blood cell (WBC) count (leukopenia) in a patient with anaemia should 
lead to consideration of bone marrow suppression or replacement, hypersplenism, or 
deficiencies of cobalamin(B12) or folate. In comparison, a high total WBC count 
(leukocytosis) may reflect the presence of infection, inflammation, or a hematologic 
malignancy. 
Clues to the specific abnormality present may be obtained from the WBC differential, which, 
in conjunction with the total WBC may show increased or decreased absolute numbers of 
the various cell types in the circulation. Examples include: 
- An increased absolute neutrophil count in infection or steroid therapy 
- An increased absolute monocyte count in myelodysplasia 
- An increased absolute eosinophil count in certain infections 
- A decreased absolute neutrophil count following chemotherapy 
- A decreased absolute lymphocyte count in HIV infection or following treatment with 
corticosteroids.  
4.6 Neutrophil hypersegmentation 
Neutrophil hypersegmentation (NH) is defined as the presence of >5 percent of neutrophils 
with five or more lobes and/or the presence of one or more neutrophils with six or more 
lobes. This peripheral smear finding, along with macro-ovalocytic red cells, is classically 
associated with impaired DNA synthesis, as seen in disorders of vitamins B12 and folic acid.  
4.7 Circulating nucleated red blood cells 
Nucleated RBCs (NRBCs) are not normally found in the circulation. They may be present in 
patients with known hematologic disease (eg, sickle cell disease, thalassemia major, various 
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haemolytic anaemia after splenectomy), or as a part of the leukoerythroblastic pattern seen 
in patients with bone marrow replacement. 
In patients without known hematologic disease, NRBCs may reflect the presence of a life-
threatening disease, such as sepsis or severe heart failure.  
4.8 Platelet count 
Abnormalities in the platelet count often provide important diagnostic information. 
Thrombocytopenia occurs in a variety of disorders associated with anaemia, including 
hypersplenism, marrow involvement with malignancy, autoimmune platelet destruction 
(either idiopathic or drug-related), sepsis, or folate or cobalamin deficiency. 
High platelet counts, in comparison, may reflect myeloproliferative disease, chronic iron 
deficiency, and inflammatory, infectious, or neoplastic disorders. Changes in platelet 
morphology (giant platelets, degranulated platelets) also may be important, suggesting 
myeloproliferative or myelodysplastic disease. 
4.9 Pancytopenia 
The combination of anaemia, thrombocytopenia, and neutropenia is termed pancytopenia. 
The presence of severe pancytopenia narrows the differential diagnosis to disorders such as 
aplastic anaemia, folate or cobalamin deficiency, or hematologic malignancy (eg, acute 
myeloid leukaemia). Mild degrees of pancytopenia may be seen in patients with 
splenomegaly and splenic trapping of circulating cellular elements(hypersplenism).  
4.10 Blood smear 
Many clinicians rely on the above RBC parameters and the RDW in evaluating a patient 
with anaemia. However, the RDW is of limited utility, and examination of the peripheral 
blood smear provides information not otherwise available. 
As examples, the automated counter may miss the red cell fragmentation ("helmet cells", 
schistocytes) of microangiopathic haemolysis, microspherocytes in autoimmune haemolytic 
anaemia, teardrop RBCs in myeloid metaplasia, a leukoerythroblastic pattern with bone 
marrow replacement, the "bite cells" in oxidative haemolysis, or RBC parasites such as 
malaria or babesiosis.  
4.11 Serial evaluation of haemoglobin and hematocrit 
Measuring the rate of fall of the patient's Hb or HCT often provides helpful diagnostic 
information. Suppose the Hb concentration has fallen from 15 to 10 g/dL in one week. If this 
were due to total cessation of RBC production (ie, a reticulocyte count of zero) and if the rate 
of RBC destruction were normal (1 percent/day), the Hb concentration would have fallen by 
7 percent over seven days, resulting a decline of 1.05 g/dL (0.07 x 15). The greater fall in Hb 
in this patient (5 g/dL) indicates that marrow suppression cannot be the sole cause of the 
anaemia and that blood loss and/or increased RBC destruction must be present. 
4.12 Evaluation for iron deficiency 
More complete evaluation for iron deficiency is indicated when the history 
(menometrorrhagia, symptoms of peptic ulcer disease) and preliminary laboratory data (low 
MCV, low MCH, high RDW, increased platelet count) support this diagnosis. In this setting, 
the plasma levels of iron, iron binding capacity (transferrin), transferrin saturation, and 
ferritin should be measured. This is discussed in detail below. 
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4.13 Evaluation for haemolysis 
Haemolysis should be considered if the patient has a rapid fall in haemoglobin 
concentration, reticulocytosis, and/or abnormally shaped RBCs (especially spherocytes or 
fragmented RBCs) on the peripheral smear. The usual ancillary findings of haemolysis are 
an increase in the serum lactate dehydrogenase (LDH) and indirect bilirubin concentrations 
and a reduction in the serum haptoglobin concentration. 
The combination of an increased LDH and reduced haptoglobin is 90 percent specific for 
diagnosing haemolysis, while the combination of a normal LDH and a serum haptoglobin 
greater than 25 mg/dL is 92 percent sensitive for ruling out haemolysis. 
4.14 Intravascular haemolysis 
Serum or plasma haemoglobin and urinary hemosiderin should be measured if 
intravascular haemolysis is a consideration, as with paroxysmal nocturnal 
haemoglobinuria.  
4.15 Bone marrow examination 
Examination of the bone marrow generally offers little additional diagnostic information in 
the more common forms of anaemia. If erythropoiesis is increased in response to the 
anaemia, the bone marrow will show erythroid hyperplasia, a nonspecific finding. Similarly, 
although the absence of stainable iron in the bone marrow had previously been considered 
the "gold standard" for the diagnosis of iron deficiency, this diagnosis is usually established 
by laboratory tests alone  
Indications for examination of the bone marrow in anaemic patients include pancytopenia 
or the presence of abnormal cells in the circulation, such as blast forms. Such patients may 
have aplastic anaemia, myelodysplasia, marrow replacement with malignancy, or a 
myeloproliferative disease. Other findings that may be seen in the marrow in anaemic 
patients include megaloblastic erythropoiesis (folate or cobalamin deficiency), absence of 
recognizable RBC precursors (pure RBC aplasia), vacuolization of RBC precursors (alcohol 
or drug-induced anaemia), and increased iron-laden RBC precursors (the sideroblastic 
anaemia).  
4.16 Multiple causes of anaemia 
Multiple causes are frequently present in adults, particularly the elderly. Common examples 
are: 
- A patient with gastrointestinal bleeding secondary to colon cancer may also have the 
anaemia of chronic disease, leading to a blunted reticulocyte response.  
- A patient with a chronic hemolytic anaemia (eg, sickle cell anaemia, hereditary 
spherocytosis) may develop worsening anaemia following acute infection, particularly 
with parvovirus B19, which may blunt or temporarily ablate erythropoiesis and the 
reticulocyte response.  
- A patient with autoimmune hemolytic anaemia may develop worsening anaemia from 
gastrointestinal blood loss following treatment with corticosteroids. 
- Anaemia, renal failure, and congestive failure are often found together, a condition that 
has been termed "cardio-renal anaemia syndrome." Treatment of the anaemia may 
improve both the renal failure and heart failure.  
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Algorithm for diagnosing cause of anaemia 
 
Source : Nathan, DG, Oski, FA. Hematology of Infancy and Childhood, 4th ed, WB Saunders, Philadelphia, 
PA 1993. p. 352. 
5. Anaemia due to decreased red cell production 
A variety of disorders are associated with anaemia due to decreased red cell production (ie, 
hypoproliferative anaemia). This situation is simplistically identified by the finding of a low 
corrected absolute reticulocyte count (reticulocytopenia).  
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The differential diagnosis of a hypoproliferative anaemia can often be narrowed by 
identification of one of the six specific presenting patterns outlined below. 
5.1 Normocytic anaemia without leukopenia or thrombocytopenia 
The peripheral smear in this setting demonstrates normal red blood cell (RBC) morphology. 
The red cell indices are normal or slightly hypochromic or microcytic. The white blood cell 
(WBC) count is usually normal although there may be a neutrophilic leukocytosis. The WBC 
are not dysplastic and blasts are not seen. The platelet count is usually normal or elevated. 
The platelets are not dysplastic. 
The bone marrow is usually not examined in these cases. If studied, it would show normal 
cellularity, normal maturation of the several cell lines, and normal iron stores. 
This pattern can be induced by a number of disorders- 
5.1.1 Anaemia of (chronic) inflammation 
This condition is most often associated with infection, inflammation, or malignancy. Initial 
evaluation with ESR or CRP and then focussed investigations to find a cause should be done. 
5.1.2 Mild to moderate iron deficiency 
Mild to moderate iron deficiency can be associated with anaemia without the classic 
findings of hypochromia or microcytosis.  
5.1.3 Renal failure 
The anaemia associated with renal failure is usually due to a marked reduction in 
erythropoietin (EPO) production relative to the degree of anaemia. The EPO level usually 
does not fall until the creatinine clearance drops below 30 mL/minute. Urinalysis for 
Albumin to Creatinine ratio(ACR) is helpful in detecting renal disease, especially in patients 
with Diabetes mellitus.   
5.1.4 Endocrine disorders 
A mild hypoproliferative anaemia can be seen in a number of endocrine disorders, 
including hypothyroidism, hyperthyroidism, panhypopituitarism, and primary or 
secondary hyperparathyroidism. How the anaemia occurs in these disorders is not well 
understood but correction of the endocrine disturbance usually corrects the anaemia. 
5.2 Normocytic anaemia with low to absent reticulocytes 
The presentation in this setting is similar to variant 1 with one important exception: the RBC 
morphology is normal but the reticulocyte count is very low, usually <10,000/microL, 
frequently as low as 2,000/microL, and occasionally zero. 
This pattern is highly suggestive of pure red cell aplasia. The bone marrow will show 
normal overall cellularity and morphology except for the virtual absence of all identifiable 
erythroid precursors. Giant proerythroblasts may be seen in those patients with pure red 
cell aplasia secondary to infection with parvovirus. 
There are many causes of acquired pure red cell aplasia in adults, the most common being 
idiopathic, drug-induced, myelodysplastic syndrome, T-cell large granular lymphocytic 
leukaemia, and thymoma. Regardless of the etiology, the final common pathway seems to 
be an immunologic attack, usually mediated by T cells, on erythroid progenitors at a 
maturity level between CFU-E (colony-forming units-erythroid) and proerythroblasts.  
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5.3 Normocytic anaemia with pancytopenia 
The peripheral smear in these patients usually reveals normal RBC morphology but 
macrocytosis is occasionally seen. The WBC count is low with prominent neutropenia 
(absolute neutrophil count below 1000/microL) and, in some cases, lymphopenia 
(<1000/microL) as well. WBC morphology is normal. The platelet count is reduced; the 
platelet morphology is generally normal with occasional large platelets. 
Bone marrow examination is almost always performed in patients with pancytopenia, 
usually in conjunction with cytogenetic studies. The marrow in most cases of 
hypoproliferative anaemia with pancytopenia is either profoundly hypocellular with 
relatively normal morphology of the remaining elements or hypocellular with dysplasia of 
red cell, neutrophil, and platelet precursors. In some patients, however, the marrow is 
totally replaced with malignant cells or fibrosis. 
Pancytopenia without prominent morphologic abnormalities has a very different set of 
clinical implications from isolated anaemia. The major causes of this problem include: 
- Aplastic anaemia 
- Bone marrow suppression following chemotherapy and/or radiation therapy 
- Hypoplastic myelodysplastic syndrome 
- Marrow replaced by leukaemia, lymphoma, cancer, or rarely, fibrosis 
Although splenomegaly can also cause pancytopenia (ie, hypersplenism), the increased 
peripheral destruction seen in hypersplenism is associated with enhanced erythropoiesis 
and a high reticulocyte count, and the bone marrow is normocellular to hypercellular, rather 
than aplastic or hypocellular. 
5.4 Macrocytic non-megaloblastic anaemia 
The peripheral smear in this disorder shows RBCs that are distinctly macrocytic with very 
few macroovalocytes. The mean cell volume (MCV) is generally greater than 100 fL. The 
WBC may be slightly low but there is no dysplasia or blasts. Few, if any, five to six lobed 
neutrophils are present. The platelet count may be normal or as low as 50,000/microL. 
The bone marrow is usually not examined in this setting but, if performed, cellularity and 
maturation are normal. Megaloblastosis, characteristic of cobalamin or folate deficiency, is not 
seen.  
Several disorders can produce a hypoproliferative, macrocytic anaemia without 
megaloblastosis-  
- Alcohol abuse  
- Therapy with zidovudine(AZT), other anti-viral agents, hydroxyurea, methotrexate, 
phenytoin 
- Myelodysplastic syndrome, early in its course 
- Early in the course of cobalamin or folate deficiency. 
5.5 Macrocytic megaloblastic anaemia 
The peripheral smear in this setting reveals macrocytic RBCs with macroovalocytes. The 
WBC count is normal or low, but the neutrophils show hypersegmentation with at least 5 
percent of the cells having five or more lobes. The platelet count is normal or low. 
These findings are highly suggestive of folate or cobalamin (vitamin B12) deficiency. Bone 
marrow examination is usually not necessary. 
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5.6 Leucoerythroblastic anaemia 
The peripheral smear in a patient with a leukoerythroblastic anaemia shows abnormal RBC 
morphology with tear-drop forms, elliptocytes, macrocytes, and circulating nucleated RBC. 
The WBC count may be high, low, or normal, but there is myeloid immaturity extending 
back to the myeloblast stage. The platelet count is usually low with abnormal morphology, 
including giant platelets and even megakaryocyte fragments. 
A leukoerythroblastic picture reflects replacement of the bone marrow by granulomas, 
cancer, fibrosis, or primary myelofibrosis (PMF). The remaining pluripotent stem cells move 
to the liver and spleen as they did in fetal life, resulting in extramedullary hematopoiesis. 
The stromal support system in the liver and spleen is not optimal, as it is in the marrow. As 
a result, hematopoietic cells are released prematurely or abnormally into the circulation. The 
reticulocyte count is of limited value in this setting because extramedullary hematopoiesis is 
associated with both disordered release of reticulocytes into the peripheral blood and 
disordered maturation of nucleated RBC to reticulocytes in the peripheral circulation. 
Having recognized the virtually pathognomonic peripheral smear findings, the differential 
diagnosis focuses on what is replacing the marrow. Therefore, a bone marrow biopsy 
(aspiration may result in a dry tap) with appropriate staining (for reticulin and collagen) is 
necessary. There are two major causes: 
-Metastatic cancer. 
-Myelofibrosis, as seen in the myeloproliferative syndromes such as PMF or myelofibrosis 
associated with acute myeloid leukaemia, other cancer, or radiation.  
The differential diagnosis of a hypoproliferative anaemia with microcytosis, which is most often 
due to iron deficiency, is discussed below.  
6. Anaemia due to iron deficiency 
The development of iron deficiency, and the rapidity with which it progresses, is dependent 
upon the individual's initial iron stores which are, in turn, dependent upon age, sex, rate of 
growth and the balance between iron absorption and loss.  
Causes of iron deficiency are discussed below. 
6.1 Blood loss 
The major cause of iron deficiency in affluent countries is blood loss, either overt or occult. 
Overt blood loss is, by definition, obvious and not difficult for the clinician to recognize, 
often by history alone. Examples include severe traumatic haemorrhage, haematemesis, 
malena, haemoptysis, severe menorrhagia and gross haematuria. 
Occult bleeding, on the other hand, may be difficult to track down. This usually occurs via 
the gastrointestinal tract in men. Other causes are repeated voluntary blood donations, the 
post-operative setting in which blood loss greatly exceeds the amount of blood transfused, 
or iatrogenic anaemia due to repeated and massive blood drawing in the course of workup 
of a complicated medical condition. Additional factors are often responsible in women, 
including underestimating the degree of menometrorrhagia, blood loss during delivery, and 
direct iron loss to the fetus during pregnancy and to the neonate during lactation. 
Although reduced gastrointestinal absorption of iron and a diet deficient in iron can also 
cause iron deficiency, it is most reasonable to believe, as a first assumption, that iron 
deficiency reflects blood loss, in order to avoiding missing an occult malignancy or other 
bleeding intestinal lesion.  
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6.2 Decreased iron absorption 
Gastrointestinal malabsorption of iron is a relatively uncommon cause of iron deficiency, 
although it may be observed in certain diseases associated with generalized malabsorption 
or achlorhydria [5]. However, the use of proton pump inhibitors, which reduce gastric acid 
secretion, has not been associated with clinical iron deficiency. 
6.3 Foods and medications 
There are a number of foods and medications that impair absorption of iron.  
 
Absorption of haem iron is affected by: 
Amount of haem iron, especially in meat 
Content of calcium in the meal (calcium impairs iron absorption) 
Absorption of nonhaem iron is affected by: 
Iron status 
Amount of potentially available nonhaem iron 
Balance between positive and negative factors 
Positive factors 
Ascorbic acid 
Meat or fish (haem iron enhances absorption of nonhaem iron) 
Negative factors 
Phytate (in bran, oats, rye fibre) 
Polyphenols (in tea, some vegetables and cereals) 
Dietary calcium 
Soy protein 
6.4 Coeliac disease 
Iron deficiency anaemia, refractory to oral iron treatment can be seen in patients with coeliac 
disease, autoimmune atrophic gastritis or Helicobacter pylori infection. It is unclear whether 
there is a component of blood loss contributing to iron deficiency in this condition, although 
a component of the anaemia of chronic disease (inflammation) is seen in some individuals. 
6.5 Other causes 
There are several other uncommon causes of iron deficiency: 
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6.5.1 Intravascular haemolysis 
Intravascular haemolysis, with its accompanying haemoglobinuria and hemosiderinuria can 
lead to significant urinary iron losses in patients with paroxysmal nocturnal 
haemoglobinuria and in cardiac patients with intravascular destruction of red cells 
secondary to malfunctioning valvular prostheses, patches, or intracardiac myxomas.  
6.5.2 Pulmonary hemosiderosis 
Pulmonary hemosiderosis (eg, chronic pulmonary haemorrhage in anti-glomerular 
basement membrane antibody disease) can appear as functional iron deficiency.  
6.5.3 Response to erythropoietin 
A response to treatment with erythropoietin (EPO) for the anaemia of chronic renal failure 
often leads to iron deficiency, since the iron requirements generated by this response can 
usually not be met by mobilization of the patient's iron stores alone.  
6.5.4 Gastric bypass for morbid obesity 
This form of surgery bypasses the duodenum, the major site of intestinal iron absorption. 
As a result, iron deficiency can occur following gastric bypass surgery, not only through the 
bypassing of the site of major iron absorption, but also as the result of decreased gastric acid 
availability.  
6.5.5 Congenital iron deficiency 
Rare families with iron deficiency anaemia unresponsive to oral iron therapy, but partially 
responsive to parenteral iron, have been reported. 
6.6 Estimation of iron stores  
The patient's history, complete blood count, red blood cell indices, and examination of the 
peripheral blood smear usually allow the clinician to make a presumptive diagnosis of iron 
deficiency anaemia. This can be followed by a therapeutic trial of iron administration to 
provide both confirmation of the diagnosis and therapy. 
6.6.1Therapeutic trial of iron 
A presumptive diagnosis of iron deficiency anaemia is made if there is a positive response to 
a trial of oral iron therapy, characterized by a modest reticulocytosis beginning in about five 
to seven days, followed by an increase in haemoglobin at a rate of about 2 to 4 g/dL every 
three weeks until the haemoglobin concentration returns to normal. 
The limitation of this approach occurs if there is no response, or the response is modest or 
incomplete. In this setting, the clinician cannot differentiate among poor patient compliance, 
inability to absorb the iron preparation, an incorrect diagnosis, continued bleeding, or a 
coexisting condition such as the anaemia of chronic disease or renal failure that blocks the 
full reticulocyte response. 
For these reasons, laboratory tests (eg, iron studies, iron panel) are often ordered to confirm 
the diagnosis prior to initiation of therapy.  
6.6.2 Serum or plasma ferritin 
The serum or plasma ferritin concentration is an excellent indicator of iron stores in otherwise 
healthy adults and has replaced assessment of bone marrow iron stores as the gold standard 
www.intechopen.com
 
Diagnostic Evaluation of Anaemia  
 
87 
for the diagnosis of iron deficiency in most patients. There is no clinical situation other than 
iron deficiency in which extremely low values of serum ferritin are seen.  
6.6.3 Pregnancy 
Serum ferritin is useful in diagnosing iron deficiency in pregnant women, who often have 
an elevated serum transferrin in the absence of iron deficiency. 
6.6.4 Inflammatory states 
Ferritin is an acute phase reactant, with plasma levels increasing in liver disease, infection, 
inflammation, and malignancy.  
6.6.5 Serum iron and transferrin (TIBC) 
In iron deficiency anaemia, the serum iron concentration (SI) is reduced, and the level of 
transferrin - also measured as total iron binding capacity (TIBC) is elevated; the latter 
finding reflects the reciprocal relationship between serum iron and transferrin gene 
expression in most nonerythroid cells.  
The accuracy of measurement of transferrin/TIBC for predicting the presence of iron 
deficiency is second only to the serum or plasma ferritin concentration. Confounding factors 
are pregnancy and oral contraceptives, which increase the plasma transferrin concentration.  
6.6.6 Bone marrow iron 
Iron in bone marrow macrophages and erythroid precursors (sideroblasts) can be detected 
with the Prussian Blue stain on marrow spicules. Lack of stainable iron in erythroid 
precursors as well as marrow macrophages is considered by most clinicians to be the "gold 
standard" for the diagnosis of iron deficiency. In contrast, in uncomplicated anaemia of 
chronic disease, iron is present in marrow macrophages but absent or reduced in erythroid 
precursors. 
However, bone marrow sampling and testing for stainable iron is expensive, invasive, and 
usually unnecessary. It has been replaced in practice by measurement of serum ferritin. 
6.6.7 Assessment of iron sufficiency 
Serum ferritin is often ordered to assess whether the patient is iron sufficient, rather than 
deficient. Similarly, defining iron sufficiency for the purpose of predicting a response in 
anaemic patients with chronic renal insufficiency to treatment with erythropoietin requires a 
relatively high amount of available iron, usually stated as a serum ferritin ≥100 ng/mL and 
a transferrin saturation ≥20 percent.  
6.6.8 Red cell morphology and indices 
Despite the classic description of iron deficiency as leading to a hypochromic, microcytic 
anaemia, many iron deficient patients in western countries will have normal red cell 
morphology. Further, the finding of a hypochromic microcytic anaemia is not 
pathognomonic of iron deficiency, with thalassemia and, less commonly, the anaemia of 
chronic inflammation being the other common conditions encountered in daily practice. It is 
important to rule out these disorders before beginning a trial of iron therapy, since many 
patients with thalassemia or chronic inflammation are already iron overloaded. 
www.intechopen.com
 
Anemia 
 
88
7.Evaluation of anaemia due to blood loss  
7.1 Upper and lower GI evaluation 
Upper and lower GI investigations should be considered in all postmenopausal female and 
all male patients where Iron Deficiency anaemia(IDA) has been confirmed unless there is a 
history of significant overt non-GI blood loss.  
In the absence of suggestive symptoms (which are unreliable), the order of investigations is 
determined by local availability, although all patients should be screened for coeliac disease 
with serology. Small-bowel biopsy samples should be taken at OGD if coeliac serology was 
positive or not performed.  
If oesophago-gastro-duodenoscopy (OGD) is performed as the initial GI investigation, only 
the presence of gastric cancer or coeliac disease, as explained below, should deter lower GI 
investigation. In particular, the presence of oesophagitis, erosions and peptic ulcer disease 
should not be accepted as the cause of IDA until lower GI investigations have been carried 
out.  
Colonoscopy has the following advantages over radiology: it allows biopsy of lesions, 
treatment of adenomas, and identification of superficial pathology such as angiodysplasia 
and NSAID damage. Performing gastroscopy and colonoscopy at the same session speeds 
investigation and saves time for both the hospital and the patient, because only one 
attendance for endoscopy is required.  
Radiographic imaging is a sufficient alternative where colonoscopy is contraindicated. The 
sensitivity of CT colonography for lesions >10 mm in size is over 90%. Barium enema is less 
reliable, but is still useful if colonoscopy or CT colonography are not readily available.  
7.2 Screening for and further investigation of coeliac disease 
Ideally coeliac serology—tissue transglutaminase (tTG) antibody or endomysial antibody, if 
tTG antibody testing is not available—should be undertaken at presentation. But if this has 
not been carried out or if the result is not available, duodenal biopsy specimens should be 
taken. If coeliac serology is negative, small-bowel biopsies need not be performed at OGD 
unless there are other features, such as diarrhoea, which make coeliac disease more likely. If 
the tTG antibody test is negative, the post-test probability of coeliac disease is 0.3%, which is 
less than in the general population. If coeliac serology is positive, coeliac disease is likely 
and should be confirmed by small-bowel biopsy.  
7.3 Further evaluation 
Further imaging of the small bowel is probably not necessary unless there is an inadequate 
response to iron therapy, especially if transfusion dependent. In those with an inadequate 
response, video capsule endoscopy or enteroscopy may be helpful to detect angiodysplasia, 
Crohn's disease and small-bowel neoplasia.  
Video capsule endoscopy has a diagnostic yield of 40–55% in this setting. However, it 
seldom results in a beneficial subsequent intervention. Many lesions detected by both 
enteroscopy and video capsule endoscopy are within the reach of a gastroscope, and repeat 
OGD should be considered before these procedures. Bleeding lesions identified by video 
capsule endoscopy may be amenable to treatment by push or double-balloon enteroscopy. 
However, the benefits of these procedures after a normal video capsule endoscopy in the 
context of IDA are unproven.  
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Small-bowel imaging (MRI enteroclysis, CT enterography or barium studies) should also be 
considered in patients with symptoms suggestive of small-bowel disease, transfusion-
dependent IDA, and rapid recurrence of anaemia after normalisation of Hb concentrations. 
However, many small intestinal lesions that cause asymptomatic anaemia are mucosal and 
flat or nearly so and most small intestinal imaging modalities apart from video capsule 
endoscopy are only efficient at identifying mass lesions. CT has the additional advantage of 
being able to identify extraintestinal pathology such as renal tumours and lymphomas.  
Helicobacter pylori colonisation may impair iron uptake and increase iron loss, potentially 
leading to iron deficiency and IDA. Eradication of H pylori appears to reverse anaemia in 
anecdotal reports and small studies. H pylori should be sought by non-invasive testing, if 
IDA persists or recurs after a normal OGD and colonoscopy, and eradicated if present. H 
pylori urease (CLO) testing of biopsy specimens taken at the initial gastroscopy is an 
alternative approach.  
Autoimmune gastritis has been identified as a potential cause of IDA in up to a quarter of 
cases, but, although of interest, its diagnosis is currently of little practical value.  
Giardia lamblia has occasionally been found during the investigation of IDA. If there is 
associated diarrhoea, then small-bowel biopsy samples will be taken anyway and may 
detect this. Where giardiasis is suspected, stool should be sent for ELISA, even if histology 
of duodenal biopsy samples is negative.  
Radiological imaging of the mesenteric vessels is of limited use but may be of value in 
transfusion-dependent IDA for demonstrating vascular malformations or other occult 
lesions. There is no evidence to recommend labelled red cell imaging or Meckel's scans in 
patients with IDA. Faecal occult blood testing is of no benefit in the investigation of IDA, 
being insensitive and non-specific. 
8. Evaluation of anaemia due to increased destruction 
Hemolytic anaemia is defined as anaemia due to a shortened survival of circulating red 
blood cells (RBCs). Although the time of RBC senescent death in adults is 110 to 120 days, it 
is convenient to define haemolysis as a shortening of RBC survival to a value of less than 100 
days. 
While there are no symptoms specific for the diagnosis of hemolytic anaemia, recognizing 
haemolysis is not difficult in the classic patient, who may have many of the following: 
- Rapid onset of pallor and anaemia 
- Jaundice with increased indirect bilirubin concentration 
- History of pigmented (bilirubin) gallstones 
- Splenomegaly 
- Presence of circulating spherocytic red cells (eg, autoimmune hemolytic  anaemia, 
congenital spherocytosis) 
- Other informative red cell shape changes (see below) 
- Increased serum lactate dehydrogenase (LDH) concentration 
- Reduced or absent level of serum haptoglobin 
- A positive direct antiglobulin test (Coombs test) 
- Increased reticulocyte percentage or absolute reticulocyte number, indicating the bone 
marrow's response to the anaemia 
Laboratory findings, including an examination of the peripheral smear, are used to confirm 
the presence of haemolysis, and, if possible, the underlying cause. 
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Common causes of hemolytic anaemia in the adult 
Hematologic consultation should be obtained in virtually all patients with a new onset of 
haemolysis, since sudden and life-threatening worsening of anaemia may occur, requiring 
urgent coordination between clinicians, clinical pathologists, and blood bank personnel for 
appropriate management.  
Haemolysis may also be the first sign of an underlying systemic disorder (eg, thrombotic 
thrombocytopenic purpura, lupus erythematosus, chronic lymphocytic leukaemia) and may 
require urgent intervention to prevent death or disease-related complications. 
8.1 Peripheral smear 
Abnormalities suspicious for the presence of haemolysis include the following: 
- Spherocytes, microspherocytes, and elliptocytes. 
- Fragmented RBC (schistocytes, helmet cells) indicating the presence of 
microangiopathic hemolytic anaemia. 
- Acanthocytes (spur cells) in patients with liver disease. 
- Blister or "bite" cells due to the presence of oxidant-induced damage to the red cell and 
its membrane. 
- RBCs with inclusions, as in Malaria, Babesiosis, and Bartonella infections. 
- Teardrop RBCs with circulating nucleated RBC and early white blood cell forms, 
indicating the presence of marrow involvement, as in primary myelofibrosis or tumor 
infiltration. 
- Red cell "ghosts" indicating the presence of intravascular haemolysis, most often 
associated with overwhelming bacterial infection (eg, Clostridium perfringens). 
8.2 Serum LDH and haptoglobin 
Two major tests used to diagnose the presence of haemolysis are lactate dehydrogenase 
(LDH), released from hemolyzed RBCs, and haptoglobin, which binds to haemoglobin 
released during intravascular or extravascular haemolysis or ineffective erythropoiesis with 
release of haemoglobin from late erythroid precursors in the bone marrow. Higher 
haptoglobin values in the presence of haemolysis can reflect either a lesser degree of 
haemolysis or concurrent inflammation, since haptoglobin is an acute phase reactant.  
The combination of an increased serum LDH and a reduced haptoglobin is 90 percent 
specific for diagnosing haemolysis, while the combination of a normal serum LDH and a 
serum haptoglobin >25 mg/dL is 92 percent sensitive for ruling out haemolysis.  
8.3 Reticulocyte count 
The normal reticulocyte percentage is 0.5 to 1.5 percent. In patients with an otherwise intact 
bone marrow, the increase in erythropoietin production induced in a patient with hemolytic 
anaemia should raise the reticulocyte percentage above 4 to 5 percent. However, when the 
bone marrow is compromised (eg, following chemotherapy, infection, underlying marrow 
disease, cobalamin, folate, or iron deficiency), the reticulocyte response may be blunted or 
ablated. 
8.4 Other tests 
Other tests helpful in determining the presence or absence of haemolysis include: 
Increased serum concentrations of indirect bilirubin from the catabolism of haemoglobin 
haem.  
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Increased mean corpuscular haemoglobin concentration (MCHC), indicating the presence of 
spherocytes. 
Positive direct antiglobulin (Coombs') test in autoimmune hemolytic anaemia.  
Tests for cold agglutinins or the Donath-Landsteiner antibody if symptoms are related to 
exposure to cold.  
Testing for the presence of insoluble globin particles within the red blood cell (ie, Heinz 
bodies).  
Increased blood concentration of carboxyhaemoglobin due to haemoglobin haem 
catabolism. 
8.5 Testing for intravascular haemolysis 
If intravascular haemolysis is suspected, the following additional tests are of value: 
- Measurement of the PLASMA haemoglobin concentration (ie, testing for 
haemoglobinemia) 
- Measurement of free haemoglobin in the urine supernatant (ie, testing for 
haemoglobinuria) 
- Testing for hemosiderin in the urine sediment ≥7 days after the incident, allowing time 
for hemosiderin-containing tubular cells to be shed into the urine 
9. Conclusion 
Anaemia is a frequent clinical finding, often leading to significant ill health and always 
requires prompt investigation and selective treatment. 
By following a simple escalation pathway from history, examination and targetted 
investigations, a diagnosis can usually be made and effective treatment applied. 
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